Comprehensive Approach to Obesity Management
Obesity management requires a multifactorial lifestyle program for at least 6-12 months, including individualized dietary intervention, increased physical activity, and behavioral modification strategies, to achieve a weight loss of 5-15% over 6 months. 1
Diagnosis and Assessment
- Use BMI as a routine diagnostic measure with country-specific cut points: ≥30 kg/m² indicating obesity and ≥25 kg/m² indicating overweight in Western countries, and ≥23 kg/m² indicating overweight in many Asian countries 1
- Measure waist circumference to assess abdominal adiposity: ≥88 cm for women and ≥102 cm for men in Western countries; ≥80 cm for women and ≥90 cm for men in Asian countries 1
- Conduct comprehensive clinical assessment to identify obesity-related complications including diabetes, hypertension, dyslipidemia, sleep apnea, and cardiovascular disease 1
First-Line Treatment: Lifestyle Modification
Dietary Intervention
- Reduce caloric intake by at least 500 kcal/day while ensuring sufficient protein, vitamins, and minerals 1
- Aim for approximately 55% of calories from carbohydrates, 10% from proteins, and 30% from fats (with ≤10% from saturated fats) 1
- Eliminate sugar-sweetened beverages to reduce daily caloric intake 2
- Focus on whole grains and reduce intake of fast food and energy-dense items 2
Physical Activity
- Recommend 150-300 minutes/week of moderate-intensity activity 1
- Implement gradual increases in activity levels based on individual fitness and capabilities 1
- For teenagers, promote 60 minutes of moderate to vigorous physical activity daily 2
Behavioral Therapy
- Implement self-monitoring, mindful eating, stimulus control, and stress management techniques 1
- Consider motivational interviewing techniques and technology-based tools to support adherence 1
- For teenagers, use a family-centered approach with the adolescent as the change agent 2
Second-Line Treatments
Pharmacotherapy
- Consider anti-obesity medications when lifestyle interventions alone are insufficient 1
- FDA-approved options include orlistat, naltrexone/bupropion, liraglutide, and other GLP-1 receptor agonists 1, 3
- Orlistat is indicated for weight loss in overweight adults (18 years and older) when used along with a reduced-calorie and low-fat diet 4
- Take orlistat as 1 capsule with each meal containing fat, not exceeding 3 capsules daily 4
- Take a multivitamin once daily at bedtime when using orlistat 4
- For adolescents with severe obesity, consider orlistat under care of an experienced clinician 2
Bariatric Surgery
- Consider for patients with BMI ≥35 kg/m² when non-surgical interventions have failed 1
- Surgical options include gastric banding, sleeve gastrectomy, and Roux-en-Y gastric bypass 1
- Bariatric surgery achieves approximately 25-30% weight loss and significant improvements in obesity-related comorbidities 1
- For adolescents with BMI far above 35 and comorbidities unresponsive to lifestyle therapy for 1 year, consider bariatric surgery 2
Treatment Goals and Monitoring
- Set realistic weight loss targets of 5-15% over 6 months, followed by long-term weight maintenance 1
- Regularly assess progress and adjust treatment approach as needed 1
- For growing teenagers, focus on weight maintenance rather than weight loss, allowing BMI to gradually decrease as height increases 2
- Tailor treatment intensity based on obesity severity and related complications 1
Important Considerations and Pitfalls
- Recognize obesity as a chronic disease requiring ongoing support, not a temporary condition 1
- Focus on overall health improvements rather than solely on weight 1
- Continue behavioral support even when using pharmacotherapy or after bariatric surgery 1
- Use respectful, non-stigmatizing language in all patient interactions 1, 2
- Weight regain is common after weight loss; long-term support is essential 2, 5
- For teenagers, avoid approaches that might induce unhealthy slimming practices or lead to eating disorders 2
- Energy restriction must be carefully monitored in adolescents to avoid compromising normal growth and development 2